08/21/2025
1:01 PM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2025
5:14 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2025
9:34 AM | Ionis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
08/08/2025
5:55 PM | Ionis Pharmaceuticals (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2025
5:44 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2025
4:28 PM | Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2025
3:53 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2025
2:56 PM | Ionis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2025
10:16 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2025
3:54 PM | HERMAN JOAN E (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2025
3:54 PM | Ionis Pharmaceuticals (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for IONS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Ionis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
07/17/2025
3:54 PM | Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2025
3:54 PM | Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2025
3:59 PM | Ionis Pharmaceuticals (Issuer)
LOSCALZO JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2025
7:54 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
8:00 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2025
5:02 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2025
6:18 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
10:15 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
3:26 PM | Ionis Pharmaceuticals (Filer)
| Form DEFA14A | |
04/25/2025
3:27 PM | Ionis Pharmaceuticals (Filer)
| Form ARS | |
04/17/2025
3:53 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
3:53 PM | Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
3:53 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
8:35 AM | BlackRock, Inc. (Filed by)
Ionis Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/16/2025
4:38 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2025
4:40 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2025
4:41 PM | Ionis Pharmaceuticals (Subject)
Jenne Kyle (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2025
3:45 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:16 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:16 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:16 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:16 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:16 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:17 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:06 PM | Ionis Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/19/2025
10:15 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
3:53 PM | Capital World Investors (Filed by)
Ionis Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
02/07/2025
10:55 AM | Ionis Pharmaceuticals (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
02/06/2025
5:26 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
5:27 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad) The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million.
Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant. See his full breakdown of the seven stocks to own now |
02/04/2025
3:56 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
6:26 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:26 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:26 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:26 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:27 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:27 PM | Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:27 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
4:43 PM | Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
4:41 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
4:01 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
4:02 PM | Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
4:03 PM | Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
3:58 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
3:59 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
6:40 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:40 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:40 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:40 PM | Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:40 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:40 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:40 PM | Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:41 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:41 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:41 PM | Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:41 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:41 PM | Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
6:31 PM | Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
6:18 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
6:19 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
6:21 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
6:22 PM | Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
6:23 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
6:25 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
6:28 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
6:29 PM | Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
6:30 PM | Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
10:29 AM | Ionis Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/06/2025
3:52 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:52 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:52 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:52 PM | Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
3:57 PM | Hayden Michael R (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
1:28 PM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:34 PM | BB BIOTECH AG (Filed by)
Ionis Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
7:55 AM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144/A | |
11/08/2024
9:52 AM | Ionis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
11/06/2024
3:06 PM | Ionis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
10:15 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
5:39 PM | Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
This stock could leave NVDA in the dust (Ad) Investing Legend Hints the End May be Near for These 3 Iconic Stocks
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast. Click to get the full details on Eric Fry's "Nvidia alternative" right here. |
10/17/2024
5:42 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
5:01 PM | Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/01/2024
5:01 PM | Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
4:19 PM | Ionis Pharmaceuticals (Filer)
| Form 424B5 | |
09/09/2024
3:33 PM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
3:23 PM | Ionis Pharmaceuticals (Filer)
| Form 424B5 | |
09/04/2024
8:43 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:43 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:51 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
MarketBeat All Access